Breaking News

CMS Proposes $9 Billion in Lump Sum Payments to Reimburse Hospitals for Past 340B Part B Drug Payment Cuts

CMS proposed rule

CMS late this afternoon proposed how it will repay 340B hospitals for $10.5 billion in illegal Medicare Part B drug payment cuts.

The U.S. Centers for Medicare & Medicaid Services plans to provide lump sum Medicare Part B drug payments to 340B [...]

Continue Reading

Breaking News

House E&C Committee Passes Two Bills That Would Create 340B Entity Reporting Requirements

Energy & Commerce Committee

The House E&C Committee passed a bill to impose reporting requirements on 340B DSH hospitals and potentially other entities. The committee passed another bill that could expose all types of 340B covered entities to separate reporting requirements.

The House Energy & Commerce Committee passed two bills today to impose 340B program reporting requirements on hospitals and other [...]

Continue Reading

Breaking News

House Subcommittee Votes on Party Lines to Impose Reporting Requirements on 340B DSH Hospitals & Potentially Other Covered Entities

Bucshon

Rep. Larry Bucshon (R-Ind.), who has led high-profile 340B-related legislation, will retire at the end of this Congress.

In a significant development, a GOP-led U.S. House health subcommittee this afternoon voted 16 to 12 along party lines to [...]

Continue Reading

Breaking News

HRSA and Prime Vendor Yank FAQs About 340B Use in Hospital Child Sites, and GAO Issues a New 340B Study

FAQ excerpt

Excerpts from 340B FAQs that HRSA (top) and the 340B prime vendor Apexus (bottom) have removed from their websites.

The U.S. Health Resources and Services Administration midday yesterday and the 340B prime vendor Apexus this morning, in connection with [...]

Continue Reading

Breaking News

GSK Extends 340B Pricing Conditions to all Covered Entities and all Products

GlaxoSmithKline wordmark and GSK logo on a building

GlaxoSmithKline and Pfizer announced updates to their 340B contract pharmacy policies to comply with new state laws that will take effect in July.

UPDATE Friday, March 31, 2023, 6:45 p.m. EDT—Story updated with comment from the National Association of Community Health Centers. Drug [...]

Continue Reading

Breaking News

Major Drug Industry and Health Center Groups Unite to Reform 340B for Patients and “True” Safety-Net Providers

ASAP 340B wordmark

PhRMA, NACHC, and and the National Hispanic Medical Association created a new group, ASAP 340B, and issued a 10-point plan to ensure that the 340B program “benefits patients and true safety-net providers, including rural hospitals.”

Pharmaceutical Research and Manufacturers of America, the National Association of Community Health Centers, and the National Hispanic Medical Association this [...]

Continue Reading

Breaking News

EMD Serono Is the Second Drug Maker Today to Impose Conditions on 340B Contract Pharmacy, and the 21st Overall

EMD Serono wordmark on building

Beginning Oct. 1, EMD Serono will extend its contract pharmacy restrictions to all 340B covered entities.

EMD Serono today became the 21st pharmaceutical manufacturer to impose conditions on 340B pricing involving drug shipments to contract pharmacies. [...]

Continue Reading

Breaking News

Bayer Is the 20th Drug Maker to Impose Conditions on 340B Contract Pharmacy

Bayer wordmark on side of building

Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy as of Oct. 1.

Bayer Healthcare Pharmaceuticals starting March 1 is imposing limits on hospitals’ replenishment orders of 340B-priced drugs shipped to contract pharmacies. [...]

Continue Reading

Breaking News

Third Circuit Court Rules for Drugmakers in 340B Contract Pharmacy Cases

Interior of Third Circuit Court courtroom

A federal appeals court ruled today that the 340B statute does not compel drug manufacturers to deliver 340B-purchased drugs "wherever and to whomever a buyer demands."

A federal appeals court in Philadelphia ruled 3-0 this morning that “Congress never said that drug makers must deliver discounted [...]

Continue Reading

Breaking News

Wall Street Journal Says Its Investigation of 340B Hospitals Raises Questions about Program’s Growth and Purpose

Screenshot of Wall Street Journal article Many Hospitals Get Big Drug Discounts.

The Wall Street Journal's long article today about hospital participation in 340B comes three months after a similar lengthy critique by The New York Times.

A growing number of hospitals that do not qualify for 340B drug discounts as disproportionate share hospitals are enrolling instead [...]

Continue Reading
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live

Sliding Sidebar

Link to spotlight on Sean Hall of Visante

Article Archives